Biz briefs: Hellaby's higher profit

Last updated 10:54 26/05/2014

Relevant offers

Industries

Real estate agents charging by the hour Greasies a weekly treat for a lifetime No turkey leftovers for spendthrift Kiwis Fish and chips take a battering Safety concerns close Lyttelton Port at night Tackling fishhooks of retirement village life Anti-miners prepare court case Technical problems delay Warehouse Boxing Day sale Boxing Day madness: Trolley shortage and shoppers fainting Sparks fly over 4G coverage ad claims

Profit upgrate for Hellaby

Operating profit for Hellaby Holdings is expected to be about $54 million, 43 per cent higher than last year, the investment company says.

Projected net profit after tax is expected to be about $25m, about 35 per cent higher than last year.

The higher forecasts reflect better year-on-year profit performances by four of the firm's five divisions, the exception being footwear, Hellaby managing director John Williamson said.

Hellaby, an NZX-listed investment holding company with a portfolio of 15 industrial, distribution and retail businesses, will release its results for the year to June 30 in late August.

Pacific Edge signs US deal

Pacific Edge today announced a new North American deal designed to boost sales of its bladder cancer detection system, known as Cxbladder.

The NZX-listed company said it had signed an agreement for diagnostics laboratory, testing with United States national provider network MultiPlan Inc.

Dunedin-based Pacific Edge said the agreement included Pacific Edge's participation in the MultiPlan, PHCS and PHCS Savility Networks, which would mean the Cxbladder test became more widely available to US consumers.

Pacific Edge's shares were boosted on previous announcements of these deals and this morning were trading 6 cents higher at $1.05.

Ad Feedback

- Stuff

Special offers

Featured Promotions

Sponsored Content